Charlotte is a second year PhD candidate in the Department of Pharmacology (Faculty of Medicine, Nursing and Health Sciences) at Monash University. She works under the supervision of A/Prof Brad Broughton, Prof/ Francine Marques and A/Prof Barbara Kemp-Harper. Her research investigates acute inflammatory responses in brain regions distal to the ischaemic core following ischaemic stroke.

Tina Ung, BPharm (Hons I), is a Community Pharmacist, Education-Focussed Academic and PhD Candidate at The University of Sydney School of Pharmacy. Tina is the grateful recipient of the Elizabeth Wunsch Postgraduate Research Scholarship in Mental Health and Pharmacy Services. Tina's thesis explores how we can partner with mental health stakeholders to co-design, deliver and evaluate pharmacy education and continuing professional development activities in mental health via simulated patients. Tina looks forward to presenting her research at the ASCEPT-APFP-APSA Joint Congress 2024.

Zefeng Zhao is a lecturer of Shaanxi University of Chinese Medicine, served for Shaanxi Key Laboratory of Acupuncture & Medicine. Dr Zhao obtained his PhD degree from Northwest University in 2020 majored in Traditional Chinese Medicine. Dr Zhao is primarily engaged in drug discovery and research on mechanisms of actions in epilepsy. He excavated several precursors from Traditional Chinese Medicine and investigated the mechanisms of actions in in curing epilepsy. In the past years, Dr Du has published papers in European Journal of Medicinal Chemistry, Bioorganic Chemistry, Food Chemistry, Medicinal Chemistry Research, Journal of Ethnopharmacology, Arabian Journal of Chemistry. The research has been funded by National Natural Science Foundation of China.

PI of the National Center for Pharmaceutical Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College. He obtained his Ph.D. in Pharmacology from Peking Union Medical College in 2009. From 2013 to 2015, he completed a postdoctoral fellowship program at the University of Manchester in the UK. In 2015, he returned to China and served as editorial board member of such journals as Pharmaceutical Research Modern Chinese Medicine, International Journal of Drug Discovery and Pharmacy (IJDDP), Allergy Medicine, Chinese Journal of Arteriosclerosis, Herald of Medicine, Chinese Pharmaceutical Journal, Pharmacology and Clinics of Chinese Materia Medica, etc. His research interests are cardio-cerebrovascular pharmacology and new drug discovery. He has published more than 60 research papers in Nature Communications, British Journal of Pharmacology, Acta Pharmaceutica Sinica B and other well-known journals. He has applied for 10 national invention patents and 6 grants. He participated in the compilation (translation) of 22 books, and the research and development and application of new drugs such as new Nirendipine tablets, Baikeli chewable tablets and Salvianolic acid A. He has won Natural Science Award of the Ministry of Education, Beijing Science and Technology Progress Award, and China Medical Science and Technology Award.

Tomomi Sano was earned Ph.D. (Dental Science) from Hiroshima University. I became an Assistant Professor in Department of Periodontology, Faculty of Dental Science, Kyushu University in 2016. Current Position is an Assistant Professor in Department of Cell Biology, Aging Science, and Pharmacology, Faculty of Dental Science, Kyushu University from 2020. The worsening of periodontal disease has a negative impact on the health of the entire body I believe that by treating periodontal disease appropriately, it is possible to maintain oral health and promote the health of the entire body. Therefore, I am conducting research to clarify the mechanism by which local inflammation amplified by the progression and chronicity of periodontal disease affects organs throughout the body. I am also interested in research aimed at discovering substances with anti-inflammatory effects and applying them to periodontal disease.

Dr. Yassmin Samak is an Education-Focussed Lecturer in Monash University’s Faculty of Pharmacy and Pharmaceutical Sciences with over 15 years of teaching experience. She holds a PhD in Pharmaceutical Sciences from the University of Queensland, with research focused on drug delivery systems. Dr. Samak’s teaching emphasises innovative, team-based learning activities that apply knowledge and skills to real-world pharmaceutical science and pharmacy practice. Her excellence in education has earned her prestigious awards, including the Australian Award for University Teaching (2022), Monash’s Vice-Chancellor’s Award for Excellence (2021), and the Faculty Teaching Award (2020).

Thilini is a dedicated academic with a multifaceted career as a pharmacist, teacher, and researcher. Her research activities focus on improving chronic disease management among culturally and linguistically diverse (CALD) populations and optimising the quality use of complementary medicines. Her research aims to identify strategies to prevent and manage cardiometabolic diseases. Thilini employs a variety of methodologies, including qualitative interviews and intervention trials, to develop and implement strategies that enhance the quality of care provided to people from CALD backgrounds. Thilini is also interested in exploring innovative approaches to improving the quality use of complementary medicines, striving to bridge the gap between traditional and modern medicine. Her research endeavours focus on enhancing the understanding and application of complementary medicines through dosage form design, aiming to ensure their safe and effective integration into healthcare practices.

Shin is a pharmacist and research fellow at the Centre for Medicine Use and Safety (CMUS) at Monash University. Her research focuses on optimising medication management for frail older populations, including community-dwelling individuals with dementia and aged care residents. Driven by a passion for enhancing the quality use of medicines, she aims to advance ageing research by reducing unnecessary and potentially inappropriate medication use, thereby mitigating medication-related harms in older Australians. In addition to her research, Shin serves as Chair of the Australian Association of Gerontology (AAG) Victorian Student and Early Career Group and as a member of the Australian Deprescribing Network (ADeN) committee.

Female, Professor, Ph D, Chief Pharmacists, Clinical Trial Center, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, P R. China. Master's Supervisor of Peking Union Medical College, Institute of Geriatrics, Beijing Hospital and Shenyang Pharmaceutical University. Main research directions include Clinical Pharmacology, Pharmacometrics and Clinical Research of new drugs & Analysis Techniques. More than 20 years engaged in clinical pharmacology research. Completed more than 150 phase I clinical studies of new drugs as the Principal Investigator or co-investigator. Published more than 130 papers in SCI and domestic core journals.

Yali Deng has completed her Bachelor of Biomedicine (Honours) at The University of Melbourne in 2021 and is currently a third-year PhD candidate at St Vincent’s Institute of Medical Research, specialising in cardio-oncology. Her research focuses on the role of dynamin-related protein 1 (Drp1) in protecting against anthracycline-induced cardiomyopathy, utilising advanced research models such as human induced pluripotent stem cells, cardiac tissue engineering, microfluidics, and murine models. Passionate about translational research, Yali aims to bridge the gap between basic and clinical science to accelerate drug development. She has previously worked as a business development intern under Research Innovation and Commercialisation stream at The University of Melbourne, helping researchers to translate their discoveries into practical applications.

Fang LianHua, Ph.D., Professor and PI in Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College. Main research filed is cardiovascular pharmacology and new-drugs discovery in related diseases. Especially, research of drug targets for the cardiovascular diseases, Establishment of screening model of high-throughput screening, further evaluation of active compounds obtained from high-throughput screening, etc. The member of the 11th council of the Chinese Pharmacological Society (CPS) and vice chairman of the crystal pharmacology special committee of the CPS and executive committee member of the Tonifying Drugs of the CPS, etc. Editorial board member of “Chinese Pharmaceutical Journal”, “Acta Laboratorium Animalis Scientia Sinica”, and “Pharmacology and Clinics of Chinese Materia Medica”, etc. Leaded 3 general projects of the National Natural Science Foundation of China; published over 150 academic papers; Authorized 14 China patents; Two monographs by the deputy editor in chief; Participated in the completion of preclinical research for four national Class 1 new drugs. Received second prize of Beijing Science and Technology Award, second prize and third prize of Chinese Medical Science and Technology Award, and third prize of Academic Works Award of the Chinese Association of Traditional Chinese Medicine.

Aisyah is a PhD candidate in Pharmacology at the Faculty of Pharmacy, Universiti Teknologi MARA, Malaysia. Her doctoral research explores the immunomodulatory potential of a traditional medicinal plant, which focuses on its effects and underlying mechanism against inflammation and oxidative stress. She earned her Bachelor’s degree in medicine and surgery from Alexandria University, Egypt, and previously served as a medical officer. Currently, she is a trainee medical lecturer in the Department of Pharmacology, Faculty of Medicine, Universiti Teknologi MARA, where she continues to cultivate her passion and advance her research skills in Pharmacology.

Dr. Hwang’s laboratory employs pharmacological approaches to elucidate the molecular mechanisms driving the inflammatory response of human neutrophils and to identify potential therapeutic targets for treating neutrophil-associated diseases, including acute respiratory distress syndrome, asthma, diabetics, liver injury and fibrosis, psoriasis, and arthritis. His research has identified drug-lead compounds that target critical receptors or molecules to regulate the neutrophilic inflammatory response, potentially contributing to the development of innovative therapies. Dr. Hwang has published over 496 research papers and holds 40 patents. He has also initiated 20 industry-academia collaboration projects and facilitated four technology transfers with various companies, highlighting the significant medical applications of his research. Dr. Hwang holds several key positions in academic organizations in Taiwan. He is the President of the Society for Free Radical Research-Taiwan, the President of the Taiwan Association for Traditional and Complementary Medicine, and the Director of the Pharmacological Society in Taiwan. Dr. Hwang served as the Convenor of the Division of Pharmacy and Chinese Medicine, Department of Life Sciences, Ministry of Science and Technology, Taiwan, from 2017 to 2019, assisting the government in promoting and advancing academic research. In 2019, Dr. Hwang was honored to be appointed as the Honorary President of The Society of Chinese Natural Medicine in Taiwan. Dr. Hwang was invited by Frontiers, a global academic publishing organization, to create a new journal titled Frontiers in Natural Products and to serve as its Field Chief Editor starting in 2022.

Bo-Yi PAN (Lulji Taraqaz) is an indigenous Paiwan scholar from Taiwan, currently pursuing a Ph.D. in China Medical University. His research focuses on the mechanisms by which lipoproteins contribute to cardiovascular diseases related to diabetes, emphasizing both clinical pharmacology and natural products. Passionate about bridging traditional medicine with modern science, Bo-Yi aims to develop innovative therapeutic approaches that enhance health outcomes for patients.

Tadhi (Kati) Sucharitakul, is a second-year medical student at Princess Srisavangavadhana College of Medicine, Chulabhorn Royal Academy, Bangkok, Thailand. She is currently working on a skin wound healing project at the International Collaborative Medical Research Laboratory, where she is developing her research skills and gaining insights that she hopes to apply in future clinical research.

Megan is an education-focused lecturer in the faculty of Pharmacy and Pharmaceutical Sciences and a practising pharmacist. Megan has a particular interest in integrative curriculum development to enhance student learning experiences. With a background in microbiology and molecular biology, Megan continues to explore innovative ways to connect conceptual understanding of these fields with discipline-specific and generic skills, as well as seeking to incorporate diverse perspectives such as those of Indigenous Australians.

Weng, Chih-Ming is an associate professor in school of Respiratory Therapy in Taipei Medical University. His work focuses specifically on the pathological change of epithelial immune microenvironment in lung and their impact on the lung chronic disease, such as asthma. His recent publication can be found in Mucosal Immunology, Respirology and Allergy journal.

With a keen interest in geriatric medicine, research and education, Esther is currently undertaking her Doctor of Philosophy at The University of Sydney under main supervisor Professor Sarah Hilmer. Her research centres round codesigning digital solutions for older people, that optimises medication management and promotes collaboration with health care practitioners.

Maria José Alfonso Arvez is a Paraguayan pharmacist and Ph.D. candidate at Monash University, Australia, specializing in pharmacoepidemiology and health economics. She has extensive experience in pharmacovigilance and public health, having served in leadership positions at Paraguay's Ministry of Health and currently working as an international consultant for the Pan American Health Organization.

Jie is a final-year PhD candidate in the Department of Biochemistry and Pharmacology, The University of Melbourne. Under the supervision of A/Prof Graham Mackay in the Anti-Allergic Therapeutics Laboratory, her current research focuses on the role of orphan GPCR, MRGPRX2, in chronic inflammatory diseases and drug hypersensitivity reactions. She is investigating the novel mechanism of the new endogenous agonist CXCL17 on MRGPRX2 activation using GPCR assays, proteomics and high-throughput functional genomic screening.

Xin Yi Lim, a registered pharmacist from Malaysia, is pursuing her PhD at the University of Auckland, New Zealand. Supervised by Prof Jo Barnes, A/Prof Shane Scahill, and Dr Sanya Ram, Xin Yi is examining the role of the natural health products (NHPs) industry in pharmacovigilance and the regulatory landscape for NHPs pharmacovigilance in New Zealand. The project also explores the potential for conducting active surveillance studies to collect comprehensive data on the use, benefits, and potential harms associated with specific NHPs. Despite being of ‘natural’ origin, NHPs are not without risks, yet safety monitoring (pharmacovigilance) for these products remains under-explored. With upcoming changes in New Zealand's legislative frameworks for NHPs, this research is timely. This project can help better understand the current and potential future contributions of the NHPs industry to pharmacovigilance for NHPs in New Zealand and identify key research and policy priorities, particularly concerning the NHPs industry.

Nicki Kyriacou is a PhD candidate within the Sydney Pharmacy School (Bachelor Adv Sci (Hons)). She has previously supported the Ethnopharmacology Team in the Clinical Pharmacology Modelling & Simulation group to profile ethnic sensitivity for GSK R&D. Her current research aims to investigate the impact of geographic ancestry on inter-individual variability in the pharmacokinetics of tyrosine kinase inhibitors.”

Mr. Eshetie Melese Birru is a PhD candidate in Pharmacy at Curtin University, with extensive experience in research, academia, and community service. He was previously a senior lecturer and head of the Department of Pharmacology at the University of Gondar, Ethiopia. Specializing in pharmacology, Mr. Birru has a solid foundation in pharmacy and a deep commitment to advancing the field. He has published over 35 research articles in the areas of experimental and clinical pharmacology, pharmacy, and public health.

Prof Michael Barras is the Director of Pharmacy at the Princess Alexandra Hospital, Brisbane, and a Research Conjoint with the School of Pharmacy, The University of QLD (Hospital 0.8 FTE / UQ 0.2 FTE). He currently supervises 8 HDR students who are conducting research related to medication safety, health informatics and advanced scope clinical pharmacy.

My name is Angelo Don and I am a PhD Candidate at Monash University in Pharmacy Education. My topic revolves around the implementation of resilience education in pharmacy interns to ensure they have a smoother transition into sole practise. I have completed my pharmacy internship in 2022 through Monash University and have worked as a clinical pharmacist at Epworth Richmond Hospital throughout 2023; recently started working at the Alfred Hospital alongside teaching at Monash University. Education is my passion and shaping the future generation is what keeps me eager to continue practicing and educating.

Purit Kulworasreth is a 2nd year medical student at Princess Srisavangavadhana College of Medicine, Chulabhorn Royal Academy, Bangkok, Thailand.

Dr Aili Langford is a registered pharmacist, Lecturer and NHMRC Emerging Leader Research Fellow at the University of Sydney Pharmacy School. Dr Langford’s research focuses on enhancing medication safety and effectiveness through deprescribing, and the implementation of clinical practice guidelines to improve health outcomes.

Lorna is an intercalated MBChB/PhD student at the University of Otago, currently between fifth and sixth year of medical school, completing a PhD in the field of clinical pharmacology. Her PhD focuses on linking hospital prescribing data to other data sources to measure appropriate medicines use. Her current project illustrates how small definitional changes can influence results by using routinely collected prescribing data to quantify medicines use during hospital admissions. Lorna is a co-chair of the ASCEPT Student Forum, a committee member on the ASCEPT New Zealand forum, and the Editor-in-Chief of the New Zealand Medical Student Journal.

Hiba EL Masri graduated with a Doctor of Pharmacy (PharmD) from the Lebanese University. She worked in hospital settings and in the pharmaceutical industry, in Lebanon and Saudi Arabia. She had recently completed her PhD in the School of Pharmacy, University of Queensland, entitled Dynamics of patient-based benefit-risk assessment and information seeking for medication decision-making in chronic disease. Hiba’s research is focused on the quality use of medicine, with an interest in patients’ perspectives.

Jana graduated from the University of Melbourne in 2020 with a Bachelor of Science majoring in Pharmacology. She received her Honours degree in 2021 under the supervision of Prof. Alastair Stewart, with the thesis titled: “The Art and Artefact of Static Culture”. Jana then began her PhD in 2022 with Prof. Alastair Stewart focusing on the characterisation of Casein Kinase 1 delta in circadian rhythm and cancer tumorigenesis. Her research goals include advancing the use of microphysiological systems for in vitro drug discovery. She was a general committee member of the ASCEPT student forum in 2023.

Alice is a dedicated professional in the field of pharmacy with a diverse background spanning both clinical practice and academic research. Graduating with a Bachelor of Pharmacy from the University of Sydney in 2015, Alice pursued a Master of Philosophy in research, completing it in 2021. She has since accumulated extensive experience as a community pharmacist and contributed to academia as a tutor and guest lecturer at the University of Sydney. Currently, Alice is advancing her expertise through a PhD in Pharmacy Education while also serving as the Training Manager at Aspen Pharmacare. Her work integrates clinical practice with innovative educational strategies, reflecting a commitment to enhancing pharmaceutical education and training.

Mariah is a PhD candidate in A/Prof Nicola Smith's Orphan Receptor Lab at UNSW Sydney. She has been a member of ASCEPT since 2021 and has served on ASCEPT's student committee for 2 years. She has a keen interest in GPCRs, with a focus on taste receptors and the forgotten bombesin receptor, BB3.

Dr Anna-Marie Babey received her PhD from McGill University in Montreal, undertook post-doctoral work on opioid tolerance with Prof Gavril Pasternak at the Memorial Sloan-Kettering Cancer Center in New York, and with Prof Ping-Yee Law in the Department of Pharmacology at the University of Minnesota. She is currently a member of the School of Science & Technology at the University of New England, and has an extensive history of teaching and curriculum development across 9 different degree programs at 2 Australian universities. She is particularly interested in developing learning activities that enhance students’ creativity, adaptability, and critical-thinking skills as part of her commitment to education quality. She is an active member of the ASCEPT Education Forum, having previously served as Secretary, a Councillor of the IUPHAR-Education Section, a member of the Australasian core concepts of pharmacology project, and a member of the IUPHAR-Education core concepts of pharmacology research team.

Julia completed her Bachelors of Science at Monash University in 2018, majoring in Pharmacology and Physiology. She then completed her Honours in Pharmacology in 2019 under the supervision of A/Prof Jane bourke, Dr Belinda Thomas and Prof Phil Bardin. Julia began her PhD in this lab in 2020, focusing on pharmacological interventions to prevent the lung damage associated with viral induced exacerbations, which was conferred earlier this year. Julia is now working as a postdoc in the Bardin lab, continuing research on the project from her PhD'

Dr Sujita Narayan is a Research Fellow at the Institute of Musculoskeletal Health, Faculty of Medicine and Health, University of Sydney. She is an early career researcher and her main research interests are patient safety and quality use of medicines in older people. Sujita has gained experience in conducting pharmacoepidemiological research examining the quality use of medicines in older adults. Her previous work explored the trends in the utilisation of preventive and potentially inappropriate medicines in the older population, factors associated with adverse health outcomes and reducing unnecessary or harmful medicines as older adults approach end-of-life. Sujita’s current work focuses on the utilisation, efficacy and safety of commonly prescribed medicines to manage pain conditions in older adults. She’s particularly interested in the use of antidepressants and opioids, and the evidence surrounding their use in people aged 65 years and older.

Dr. Igor Iezhitsa has over 25 years of experience in pharmacology, with a career dedicated to both academia and research. He earned his PhD in Pharmacology from Volgograd State Medical University (Russia) in 1998, followed by a Doctor of Biological Science (Dr. Sci. Biol.) degree from the same institution in 2008. From 1994 to 2000, Dr. Igor was instrumental in preclinical studies of a novel class of CNS stimulants at Volgograd State Medical University. Since then, he has conducted extensive screening and preclinical evaluation of new pharmacological compounds. In 2009, Dr. Igor joined the Faculty of Medicine at Universiti Teknologi MARA (UiTM), Malaysia, as an Associate Professor of Pharmacology. He was a key figure in establishing the Centre for Neuroscience (NeuRon) at UiTM in 2013, leading the center from 2015 to 2020. He currently serves as Professor of Pharmacology at the School of Medicine, International Medical University. Dr. Igor’s research interests include neuropharmacology, neuroprotection, toxicology, and ocular pharmacology. He has published over 110 articles in indexed journals and authored five books and chapters.

Rahini Ragavan is a Lecturer (Teaching Focussed) in the Department of Physiology and Pharmacology, La Trobe University. Her PhD was in the Department of Pharmacology, Monash University and her focus was on investigating the cardiovascular effects of animal venom. She has over 8 years of experience delivering workshops, tutorials and wet practicals to undergraduate science, allied health and biomedical science students. Recently she has been involved in curriculum development for third year pharmacology subjects. Her passion is inspiring the next generation of STEM students to continue their education in research and STEM related careers. She is also interested in collaborating with other academics in education research, more specifically how to retain long term student engagement and involvement in STEM courses.

Dr Ross O’Shea is a teaching focussed Associate Professor in Pharmacology at La Trobe University. Ross gained his PhD from the University of Melbourne in 1997 in neuropharmacology and worked as a biomedical researcher until 2010 before moving to La Trobe. Ross now teaches pharmacology to students from a variety of science and allied health courses, as well as coordinating the Bachelor of Science degree. He is passionate about student engagement and designing authentic assessments that ensure academic integrity in a world where generative artificial intelligence is improving rapidly.

Dr. Riana Rahmawati, PhD, is a lecturer at the Faculty of Medicine, Universitas Islam Indonesia, in Yogyakarta, Indonesia. She earned her medical degree and a master’s degree in Drug Management and Policy from Universitas Gadjah Mada and completed her PhD in Pharmacy at the University of Technology Sydney. Her research focuses on pharmacoepidemiology, the use of medications and herbal remedies in patients and communities, and pharmacology education, with numerous publications in reputable journals and books. She is actively involved in efforts to improve medication literacy, medication adherence, and hypertension management in Indonesia.

Ting is a final-year PhD student at the Cardiovascular Pharmacology Laboratory of the Monash Institute of Pharmaceutical Science. She is supervised by Dr. Chengxue Helena Qin, with co-supervision from Professor Rebecca Ritchie, Associate Professor Barbara Kemp-Harper, and Dr. Elva Zhao. Ting's studies and research have been supported by the Monash Graduate Scholarship (MGS) and the Monash International Tuition Scholarship (MITS). Her doctoral research focuses on the regulation of formylpeptide receptors in cardiopulmonary diseases. She aims to understand the underlying mechanisms and identify novel therapeutic strategies to improve current treatments and outcomes for patients with cardiopulmonary diseases

Dr. Ming-Jen Hsu is a Professor and Chair at the Department of Pharmacology, Taipei Medical University, and the current Secretary-General of The Pharmacological Society in Taiwan. He completed his Ph.D. at the Graduate Institute of Pharmacology, National Taiwan University. His research specializes in signal transduction, molecular pharmacology, and drug development, with a focus on hydroxamate-based compounds as potential therapeutic agents for inflammatory diseases and cancers. In collaboration with Prof. Wei-Jan Huang (Taipei Medical University), Dr. Hsu’s team investigates the anti-inflammatory, anti-angiogenic, and anti-tumor effects of WMJ hydroxamate derivatives. He also collaborates with Professor Filippo Cottiglia (University of Cagliari) on studying natural compounds, including MAG benzofuran glycosides and MT coumarins, derived from Magydaris tomentosa, which demonstrate promising anti-inflammatory and anti-angiogenic properties. His recent work explores the role of MT116 in modulating protein phosphatase, deubiquitinases, and COX-2 degradation in LPS-activated macrophages, with a view to its application in treating chronic respiratory diseases.

Dr Liu is an Assistant Research Fellow at the State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences, and Peking Union Medical College. Her research focuses on the pathogenesis and drug discovery for metabolic diseases, including obesity, diabetes, and non-alcoholic fatty liver disease (NAFLD), with an emphasis on identifying new drug targets and treatments for conditions like insulin resistance.

Georgie Lee is a PhD candidate and Research Officer at the University of Western Australia, specialising in the quality use of medicines. Her research focuses on pharmacoepidemiology, with particular attention to potentially suboptimal medication regimens. Using dispensing claims data from the Australian Pharmaceutical Benefits Scheme (PBS), Georgie's work aims to improve methods for defining and measuring exposure to polypharmacy, as well as to describe the patterns and implications of polypharmacy within the Australian population. Her current research is focused on refining indicators of suboptimal medicine use and understanding the longitudinal trajectories of medicine exposure over time.

Aneesa is a final year student completing the Bachelor of Pharmacy with Honours at The University of Sydney. Her research focusses on improving the interdisciplinary communication skills of practising pharmacists and pharmacy students. She is interested in education development to improve the interpersonal skills of emerging health professionals to advocate for greater emphasis on collaborative patient-centred care. Aneesa has previously presented her research at the 2024 AdPha Medications Management Conference and to her academic peers at The University of Sydney.

Farhana Mollah is a final-year PhD candidate within the Breast Cancer Targeting & Drug Delivery group at the University of Sydney's Faculty of Medicine and Health. Her research focuses on validating novel therapeutic candidates using 3D models for an aggressive breast cancer subtype, triple negative breast cancer. Additionally, she investigates the luteinising hormone-releasing hormone receptor in-depth to enhance targeted drug delivery.

I am an Associate Professor at the Faculty of Medicine Ramathibodi Hospital, Mahidol University, Thailand. Pornpun graduated from the University of Texas Medical Branch and was a postdoctoral researcher at the University of Alberta, Canada. I developed PharMatch, an online card game to help students learn to memorize drugs and their properties in 2021, and won an Innovative Teaching Award from Mahidol University in 2023.

Yalin Ozucelik holds a Bachelor of Arts/Bachelor of Laws from The University of Queensland, a Bachelor of Dramatic Art from the National Institute of Dramatic Art, and is a Bachelor of Pharmacy graduand and Honours candidate at the School of Pharmacy, Faculty of Medicine and Health, University of Sydney. During his Honours candidature, he co-authored a systematic review identifying the educational needs of pharmacists engaging in continuing professional development and conducted research exploring community pharmacists’ experiences of regulatory change. He looks forward to entering the profession as an intern next year.

A PhD Candidate at the University of Tasmania, Azizah brings a decade of pharmacy expertise to her research. Her current work focuses on Quality Use of Medicines and Medicines Safety in older adult populations. As an academic staff member at Universitas Syiah Kuala, Indonesia, and former pharmacist at dr. Zainoel Abidin public hospital in Banda Aceh, Indonesia, she draws from extensive clinical and educational experience. Building upon her Master of Pharmacy qualification and practical healthcare background, she aspires to implement her research findings through collaborative healthcare approaches in the future.